Summary
Intravenous anaesthetics comprise a variety of drugs that differ in chemical structure but share a suitable combination of physical properties that confer ready penetration of the blood-brain barrier. Lipid solubility is particularly important in this respect. Rapid entry into the brain is associated with rapid distribution and redistribution in the body for most of these drugs. They all readily cross the placenta to the fetus. Rate of metabolism varies between the rapidly biotransformed drugs like propanidid to the slowly metabolised ones like thiopentone. The liver is the main site of biotransformation, with the exception of propanidid which is hydrolysed by plasma pseudocholinesterase. Recovery of mental and psychomotor functions is protracted compared with inhalation anaesthetics, except after propanidid.
Thiopentone confers a two- or three-compartment open model system on the body, with an average elimination half-life of 6.2 hours: Rapid initial recovery is due to redistribution to the muscle mass. Distribution is modified by the stale ofionisalion of the drug and its magnitude of binding to plasma proteins.
Melhohexilone has an elimination half-life of 70 to 125 minutes, which is the result of a high plasma clearance rate. However, complete psychomotor recovery seems to lake the same length of time after the use of thiopentone and methohexitone in equianeasthetic doses.
Droperidol exhibits two-compartment open model kinetics with a mean elimination half-life of 2.2 hours. It is 85 to 90% bound to plasma proteins at therapeutic levels and accumulates in certain brain areas. Fentanyl has a half-life of 1 to 4 hours or more, depending on the dosage given. The drug can therefore accumulate in the body after large or multiple doses, in spile of its reputation as a short-acting narcotic.
Ketamine has a half-life of 4 hours or longer. It is poorly bound to plasma proteins. Some of its metabolites are pharmacologically active. The relation between the plasma levels of the drug and its metabolites and incidence of post-drug hallucinations and dreams need to be studied.
The kinetics of propanidid follow a one-compartment open model. It is rapidly hydrolysed in plasma and the duration of anaesthesia is influenced by pseudocholinesterase activity.
Althesin (alphadione) is a mixture of 2 steroids (alphaxalone and alphadolone). Alphaxalone is rapidly metabolised in the liver and then excreted in the urine. The pharmacokinetics of alphadolone have not been studied. The accumulation of Althesin after repealed doses and late impairment of driving skills have initial recovery may suggest the formation of pharmacologically active metabolites.
Plasma level data of intravenous diazepam can be fitted with a three-compartment open model system. It has an elimination half-life of 21 to 37 hours which is age dependent and is prolonged in patients with liver disease. It is highly bound to plasma proteins and occasionally fluctuations in plasma concentrations may coincide with subjective recurrence of drowsiness.
Etomidate is a new carboxylated imidazole derivative. Return of the drug to the central compartment from the deep peripheral compartment may be the rate controlling step in elimination of the drug. The major metabolic pathway is hydrolysis of the ethyl ester, which probably occurs mainly in the liver.
Similar content being viewed by others
References
Adoni, A.; Kapitulnik, J.; Kaufman, N.A.; Ron, M. and Blondheim, S.H.: Effect of Maternal administration of diazepam on the bilirubin binding capacity of cord blood serum. American Journal of Obstetrics and Gynecology 115: 577–579 (1973).
Altenburg, B.M.; Michenfelder, J.D. and Theye, R.A.: Acute tolerance to thiopental in canine cerebral oxygen consumption studies. Anesthesiology 31: 443–448 (1969).
Ambre, J.J.; Van Hamme, M.J.; Ghoneim, M.M. and Gross, E.G.: Pharmacokinetics of etomidate, a new intravenous anesthetic. Federation Proceedings 36: 997 (1977).
American Society of Anesthesiologists, Ad Hoc Committee: Occupational disease among operating room personnel: A national study. Anesthesiology 41: 321–340 (1974).
Andreasen, F.: The effect of dialysis on the protein binding of drugs in patients with acute renal failure. Acta Pharmacologica et Toxicologica 34: 284–294 (1974).
Andreasen, P.B.: Hendel, J.; Greisen, G. and Hvidberg, E.F.: Pharmacokinetics of diazepam in disordered liver function. European Journal of Clinical Pharmacology 10: 115–120 (1976).
Arnold, E.: A simple method for determining diazepam and its major metabolites in biological fluids: Application in bioavailability studies. Acta Pharmacologica et Toxicologica 36: 335–352 (1975).
Baird, E.S. and Hailey, D.M.: Delayed recovery from a sedative: Correlation of the plasma levels of diazepam with clinical effects after oral and intravenous administration. British Journal of Anaesthesia 44: 803–808 (1972).
Becker, Jr., K.E.: Gas chromatographic assay for free and total plasma levels of thiopental. Anesthesiology 45: 656–660 (1976).
Blackburn, C.E. and Ober, R.E.: Tritium labelling of 2-(O-chlorophenyl)-2-(methylamino) cyclohexanone (ketamine; CI-581) by acid catalyzed exchange: An example of intramolecular competition for tritium between substituted aromatic and cyclohexane rings. Journal of Labelled Compounds 3: 38–46 (1967).
Blaschke, T.F.: Protein binding and kinetics of drugs in liver disease. Clinical Pharmacokinetics 2: 32–44 (1977).
Bliding, A.: Effects of different rates of absorption of two benzodiazepines on subjective and objective parameters: Significance for clinical use and risk of abuse. European Journal of Clinical Pharmacology 7: 201–211 (1974).
Borondy, P.E. and Glazko, A.J.: Inhibition of ketamine metabolism by diazepam. Federation Proceedings 36: 938 (1977).
Boyce, J.R.; Wright, F.J.; Cervenko, F.W.; Pietak, S.P. and Faulkner, S.: Prolongation of anesthetic action of propanidid by BNPP (Bis-[P-Nitrophenyl]phosphate). Anesthesiology 45: 629–634 (1976).
Braddock, L.I. and Marec, N.: The gas chromatographic analysis of sub-microgram quantities of barbiturates using a flame ionization detector. Journal of Gas Chromatography 3: 274–277 (1965).
Brand, L.; Mark, L.C.; Snell, M.M.; Vrindten, P. and Dayton, P.G.: Physiological disposition of methohexital in man. Anesthesiology 24: 331–335 (1963).
Brand, L.; Mazzia, V.D.B.; Poznak, A.V.; Burns, J.J. and Mark, L.C.: Lack of correlation between electroencephalographic effects and plasma concentrations of thiopentone. British Journal of Anaesthesia 33: 92–96 (1961).
Breimer, D.D.: Pharmacokinetics of hypnotic drugs. Ph.D. Thesis, University of Nijmegen, The Netherlands (1974).
Breimer, D.D.: Pharmacokinetics of methohexitone following intravenous infusion in humans. British Journal of Anaesthesia 48: 643–648 (1976).
Brodie, B.B.; Mark, L.C.; Lief, P.A.; Bernstein, E. and Papper, E.M.: Acute tolerance to thiopental. Journal of Pharmacology and Experimental Therapeutics 102: 215–218 (1951).
Brodie, B.B.; Mark, L.C.; Papper, E.M.; Lief, P.A.; Bernstein, E. and Rovenstein, E.A.: The fate of thiopental in man and a method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics 98: 85–96 (1950).
Card, B.; McCulloch, R.J. and Pratt, D.A.H.: Tissue distribution of CT 1341 in the rat: An autoradiographic study. Postgraduate Medical Journal 48 (Suppl. 2): 34–37 (1972).
Carson, I.W.; Dundee, J.W. and Clarke, R.S.J.: The speed of onset and potency of Althesin. British Journal of Anaesthesia 47: 512–515 (1975).
Chang, T.; Dill, W.A. and Glazko, A.J.: Metabolic disposition of 2-(O-chlorophenyl)-2-methylaminocyclohexanone hydrochloride in laboratory animals and in man. Federation Proceedings 24: 268 (1965).
Chang, T. and Glazko, A.J.: A gas chromatographic assay for ketamine in human plasma. Anesthesiology 36: 401–404 (1972).
Chang, T. and Glazko, A.J.: Biotransformation and disposition of ketamine. International Anesthesiology Clinics 12: 157–177 (1974).
Chang, T.; Savory, A.; Albin, M.; Goulet, R. and Glazko, A.J.: Metabolic disposition of tritium-labelled ketamine (Ketalar®; CI-581) in normal human subjects. Clinical Research 18: 597 (1970).
Chaplin, M.D.; Roszkowski, A.P. and Richard, R.K.: Displacement of thiopental from plasma proteins by nonsteroidal anti-inflammatory agents. Proceedings of Society of Experimental Biology and Medicine 143: 667–671 (1973).
Chen, G.: The pharmacology of ketamine; in Kreuscher (Ed) Ketamine — Anesthesiology and Resuscitation, Vol. 40, p. 1–11 (Springer-Verlag, New York 1969).
Cherksey, B.D. and Altszuler, N.: On the mechanism of potentiation by morphine of thiopental sleeping time. Pharmacology 12: 362–371 (1974).
Child, K.J.; Gibson, W.; Harnby, G. and Hart, J.W.: Metabolism and excretion of Althesin (CT 1341) in the rat. Postgraduate Medical Journal 48 (Suppl. 2): 37–42 (1972).
Clarke, R.S.J. and Dundee, J.W.: Clinical studies of induction agents XV.: A comparison of the cumulative effects of thiopentone, methohexitone and propanidid. British Journal of Anaesthesia 38: 401–405 (1966a).
Clarke, R.S.J. and Dundee, J.W.: Experimental and clinical pharmacology of propanidid. Anesthesia and Analgesia 45: 250–262 (1966b).
Clarke, R.S.J.; Dundee, J.W. and Carson, I.W.: A new steroid anaesthetic: Althesin. Proceedings of the Royal Society of Medicine 66: 1027–1030 (1973).
Clarke, R.S.J.; Dundee, J.W. and Daw, R.H.: Clinical studies of induction agents XI: The influence of some intravenous anaesthetics on the respiratory effects and sequelae of suxamethonium. British Journal of Anaesthesia 36: 307–313 (1964).
Clarke, R.S.J.; Dundee, J.W.; Garret, R.T.; McArdle, K. and Sutton, J.A.: Adverse reactions to intravenous anaesthetics: A survey of 100 reports. British Journal of Anaesthesia 47: 575–585 (1975).
Clarke, R.S.J.; Dundee, J.W. and Zacharias, M.: Etomidate. A paper presented at the International Anesthesia Research Society meeting, Florida (1977).
Cohen, M.L.; Chan, S.L.; Way, W.L. and Trevor, A.J.: Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology 39: 370–376 (1973).
Cohen, M.L. and Trevor, A.J.: On the cerebral accumulation of ketamine and the relationship between metabolism of the drug and its pharmacological effects. Journal of Pharmacology and Experimental Therapeutics 189: 351–358 (1974).
Corssen, G.; Miyasaka, M. and Domino, E.F.: Changing concepts in pain control during surgery: Dissociative anesthesia with CI-581. A progress report. Anesthesia and Analgesia 47: 746–759 (1968).
Coutinho, C.B.; Cheripko, J.A.; Carbone, J.J.; Manning, J.E. and Boff, E.: Behavioural changes in primates and diazepam metabolism. Xenobiotica 3: 681–690 (1973).
Cressman, W.A.; Plostnieks, J. and Johnson, P.C.: Absorption, metabolism and excretion of droperidol by human subjects following intramuscular and intravenous administration. Anesthesiology 38: 363–369 (1973).
Csogor, S.I. and Kerek, S.F.: Enhancement of thiopentone anesthesia by sulphafurazole. British Journal of Anaesthesia 42: 988–990 (1970).
Cumming, J.F.: The development of an acute tolerance to ketamine. Anesthesia and Analgesia 55: 788–791 (1976).
Dawson, B.; Michenfelder, J.D. and Theye, R.: Effect of ketamine on canine cerebral blood flow and metabolism: Modification by prior administration of thiopental. Anesthesia and Analgesia 50: 443–447 (1971).
Dayton, P.G.; Perel, J.M.; Landrau, M.A.; Brand, B. and Mark, L.C.: The relationship between binding of thiopental to plasma and its distribution into adipose tissue in man, as measured by a spectrophotofluorometric method. Biochemical Pharmacology 16: 2321–2326 (1967).
Delay, J.: Psychopharmacology Frontiers (Little, Brown, Boston 1959).
de Silva, J.A.; Koechlin, B.A. and Bader, G.: Blood level distribution patterns of diazepam and its major metabolite in man. Journal of Pharmaceutical Sciences 55: 612–702 (1966).
de Silva, J.A.F. and Puglisi, C.V.: Determination of medazepam (Nobrium), diazepam (Valium) and their major biotransformation products in blood and urine by electron capture gas-liquid chromatography. Analytical Chemistry 42: 1725–1736 (1970).
Doenicke, A.: General pharmacology of propanidid. Acta Anaesthesiologica Scandinavica 17 (Suppl.): 21–26 (1965).
Doenicke, A.; Krumey, I.; Kugler, J. and Klempa, J.: Experimental studies of the breakdown of epontol: Determination of propanidid in human serum. British Journal of Anaesthesia 40: 415–429 (1968).
Doenicke, A.; Kugler, J.; Kalmar, L.; Bezecny, H.; Laub, M.; Schmidinger, K. and Slawik, B.: Klinisch Experimentelle Untersuchungen mit Propanidid. Anaesthesist 22: 255–262 (1973).
Doenicke, A.; Kugler, J. and Laub, M.: Evaluation of recovery and “street fitness” by EEG and psychodiagnostic tests after anaesthesia. Canadian Anaesthetists’ Society Journal 14: 567–583 (1967).
Doenicke, A.; Kugler, J.; Penzel, G.; Laub, M.; Kalmar, L.; Killian, I. and Bezecny, H.: Hirnfunktion und Toleranzbreite nach Etomidate, einem neuen barbituratfreien i.v. applizierbaren Hyponoticum. Anaesthesist 22: 357–366 (1973).
Dubois, M.; Allison, J. and Geddes, I.C.: The determination of alphaxalone in human blood by gas-liquid chromatography. British Journal of Anaesthesia 47: 902 (1975).
DuCailar, J.: The effects in man of infusions of Althesin with particular regard to the cardiovascular system. Postgraduate Medical Journal 48 (Suppl. 2): 72–79 (1972).
Duhm, B.; Maul, W.; Medenwald, H.; Patschke, K. and Wegner, L.A.: Tierexperimentelle Untersuchungen mit Propanidid 14C; in Horatz, Frey and Zindler (Eds) Die intravenose Kurznarkose mit dem neuen Phenoxyessigaurederivat Propanidid (Epontol), p.249–268 (Springer-Verlag, Berlin 1965).
Dundee, J.W.: Editorial: Hypersensitivity to intravenous anaesthetic agents. Brit. J. Anaes. 48: 57–58 (1976).
Dundee, J.W.; Price, H.L. and Dripps, R.D.: Acute tolerance to thiopentone in man. British Journal of Anaesthesia 28: 344–352 (1956).
Dundee, J.W. and Richards, R.K.: Effect of azotemia upon the action of intravenous barbiturate anaesthesia. Anesthesiology 15: 333–346 (1954).
Dundee, J.W. and Wyant, G.M.: Comparison of induction agents; in Dundee and Wyant (Eds) Intravenous Anaesthesia, p.300–315 (Churchill Livingstone, Edinburgh 1974a).
Dundee, J.W. and Wyant, G.M.: Tranquillisers; in Dundee and Wyant (Eds) Intravenous Anaesthesia, p.248–273 (Churchill Livingstone, Edinburgh 1974b).
Editorial: Intravenous anesthesia. Lancet 1: 962–963 (1975).
Ellingson, A.; Haram, K.; Sagen, N. and Solheim, E.: Transplacental passage of ketamine after intravenous administration. Acta Anaeslhesiologica Scandinavica 21: 41–44 (1977).
Elliott, C.J.R.; Green, R.; Howells, T.H. and Long, H.A.: Recovery after intravenous barbiturate anesthesia. Lancet 2: 68–70 (1962).
Erkkola, R.; Kanto, J. and Sellman, R.: Diazepam in early human pregnancy. Acta Obstetrica et Gynaecologica Scandinavica 53: 135–138 (1974).
Eustace, P.W.; Hailey, D.M.; Cox, A.G. and Baird, E.S.: Biliary excretion of diazepam in man. British Journal of Anaesthesia 47: 983–985 (1975).
Finster, M.; Mark, L.C.; Morishima, H.O. et al.: Plasma thiopental concentrations in the newborn following delivery under thiopental-nitrous oxide anesthesia. American Journal of Obstetrics and Gynecology 95: 621–629 (1966).
Finster, M.; Morishima, H.O.; Mark, L.C.; Perel, J.M.; Dayton, P.O. and James, L.S.: Tissue thiopental concentrations in the fetus and newborn. Anesthesiology 36: 155–158 (1972).
Forgione, A.; Martelli, P.; Marcucci, F.; Fanelli, R.; Mussini, E. and Jommi, G.C.: Gas liquid chromatography and mass spectrometry of several benzodiazepines. Journal of Chromatography 59: 163–168 (1971).
Furano, E.S. and Greene, N.M.: Metabolic breakdown of thiopental in man determined by gas chromatographic analysis of serum barbiturate levels. Anesthesiology 24: 796–800 (1963).
Garattini, S.; Marcucci, F.; Morselli, P.L. and Mussini, E.: The significance of measuring blood levels of benzodiazepines; in Davies and Prichard (Eds) Biological Effects of Drugs in Relation to Their Plasma Concentrations, p.211–225 (University Park Press, Baltimore; Churchill Livingstone, Edinburgh 1973).
Ghoneim, M.M.; Mewaldt, S.P. and Ambre, J.: Plasma levels of diazepam and mood ratings. Anesthesia and Analgesia 54: 173–177 (1975).
Ghoneim, M.M.; Mewaldt, S.P. and Thatcher, J.W.: The effect of diazepam and fentanyl on mental, psychomotor and electroen-cephalographic functions and their rate of recovery. Psychopharmacologia 44: 61–66 (1975).
Ghoneim, M.M. and Pandya, H.: Plasma protein binding of thiopental in patients with impaired renal or hepatic function. Anesthesiology 42: 545–549 (1975).
Ghoneim, M.M.; Pandya, H.B.; Kelly, S.E.; Fischer, L.J. and Corry, R.J.: Binding of thiopental to plasma proteins: Effects on distribution in the brain and heart. Anesthesiology 45: 635–639 (1976)
Ghoneim, M.M. and Van Hamme, M.J.: Unpublished results (1977).
Gilles, P.P.; De Angelis, R.J. and Wynn, R.L.: Nonlinear pharmacokinetic model of intravenous anesthesia. Journal of the Pharmaceutical Sciences 65: 1001–1006 (1976).
Godefroi, E.G.; Janssen, P.A.J.; Van Der Eycken, C.A.M.; Van Heertum, A.H.M.T. and Niemegeers, C.J.E.: DL-l-(l-arylalkyl) imidazole-5-carboxylate esters: A novel type of hypnotic agent. Journal of Medicinal Chemistry 8: 220–223 (1965).
Goldstein, A. and Aronow, L.: The duration of action of thiopental and pentobarbital. Journal of Pharmacology and Experimental Therapeutics 128: 1–6 (1960).
Greenblatt, D.J. and Koch-Weser, J.: Adverse reactions to intravenous diazepam: A report from the Boston Collaborative Drug Surveillance Program. American Journal of the Medical Sciences 266: 261–266 (1973).
Greenblatt, D.J. and Koch-Weser, J.: Clinical toxicity of chlordiazepoxide and diazepam in relation to serum albumin concentration: A report from the Boston Collaborative Drug Surveillance Program. European Journal of Clinical Pharmacology 7: 259–262 (1974).
Grieve, G.A. and Hatch, R.C.: A gas chromatographic method for determination of anesthetic and subanesthetic concentrations of thiopental in biological fluids. American Journal of Veterinary Research 33: 195–201 (1972).
Gyermek, L.: Increased toxicity of Althesin in newborn animals. British Journal of Anaesthesia 46: 704 (1974).
Halford, F.J.: A critique of intravenous anesthesia in war surgery. Anesthesiology 4: 67–69 (1943).
Henderson, G.L.; Frincke, J.; Leung, C.Y.; Torten, M. and Benjamin, E.: Antibodies to fentanyl. Journal of Pharmacology and Experimental Therapeutics 192: 489–496 (1975).
Hess, R.; Herz, A. and Friedel, K.: Pharmacokinetics of fentanyl in rabbits in view of the importance for limiting the effect. Journal of Pharmacology and Experimental Therapeutics 179: 474–481 (1971).
Hess, R.; Stiebler, G. and Herz, A.: Pharmacokinetics of fentanyl in man and the rabbit. European Journal of Clinical Pharmacology 4: 137–141 (1972).
Heykants, J.; Brugmans, J. and Doenicke, A.: On the pharmacokinetics of etomidate (R26490) in human volunteers: Plasma levels, metabolism and excretion. Janssen Pharmaceutica Research Products Information Service (1973).
Heykants, J.J.P.: Meuldermans, W.E.G.; Michiels, L.J.M.; Lewi, P.J. and Janssen, P.A.J.: Distribution, metabolism and excretion of etomidate, a short-acting hypnotic drug in the rat: Comparative study of (R)-(+) and (S)(−)- etomidate. Archives Internationale de Pharmacodynamic et de Therapie 216: 113–129 (1975).
Hillestad, L.; Hansen, T.; Melsom, H. and Drivenes, A.: Diazepam metabolism in normal man I: Serum concentrations and clinical effects after intravenous, intramuscular, and oral administration. Clinical Pharmacology and Therapeutics 16: 479–484 (1974).
Holdcroft, A.; Morgan, M.; Gordon, H.; Whitwam, J.G. and White, Y.: Althesin as an induction agent for caesarean section. British Journal of Anaesthesia 47: 1213–1217 (1975).
Howells, T.H.; Odell, J.R.; Hawkins, T.J. and Steane, P.A.: An introduction to FBA 1420: A new non-barbiturate intravenous anaesthetic. British Journal of Anaesthesia 36: 295–301 (1964).
Hug Jr., C.C. and Murphy, M.R.: Disposition of fentanyl in dogs: Correlation with ventilatory depression. Abstracts of International Anesthesia Research Society Meeting, Florida (1977a).
Hug Jr., C.C. and Murphy, M.R.: Pharmacokinetics of fentanyl in cerebrospinal fluid, plasma and urine of dogs. Federation Proceedings 36: 1000 (1977b).
Idanpaan-Keikkila, J.E.; Jouppila, P.J.; Puolakka, J.P. and Vorne, M.S.: Placental transfer and fetal metabolism of diazepam in early human pregnancy. American Journal of Obstetrics and Gynecology 109: 1011–1016 (1971).
Inaba, T.; Tsutsumi, E.; Mahon, W.A. and Kalow, W.: Biliary excretion of diazepam in the rat. Drug Metabolism and Disposition 2: 429–432 (1974).
Janicki, C.A.; Brenner, R.J. and Schwartz, B.E.: Specific assay methods for, droperidol and fentanyl citrate in a pharmaceutical combination. Journal of Pharmaceutical Sciences 57: 451–455 (1968).
Janis, K.M. and Wright, W.: Failure to produce analgesia with ketamine in two patients with cortical disease. Anesthesiology 36: 406–408 (1972).
Janssen, P.A.J.: Niemegeers, C.J.E.: Schellekens, K.H.L. and Lenaerts, F.M.: Etomidate. (R-(+)-l-(αmethyl-benzyl)imidazole-5-carboxylate) (R16659). a potent, short-acting and relatively atoxic intravenous hypnotic agent in rats. Arzneimittel Forschung 21: 1234–1243 (1971).
Jarler, J.W. and Goldbaum, L.R.: Studies on the plasma concentration and tissue distribution of sodium pentothal. Journal of Laboratory and Clinical Medicine 31: 1344–1349 (1946).
Kangas, L.; Kanto, J.; Forsstrom, J. and Iisalo, E.: Protein binding of diazepam and N-demethyldiazepam in patients with poor renal function. Clinical Nephrology 5: 114–118 (1976).
Kanto, J.: Studies of diazepam: Human and animal experiments with special reference to its pharmacokinetics. M.D. thesis. University of Turku, Finland, p. 1–69 (1976).
Kanto, J. and Erkkola, R.: The feto-maternal distribution of diazepam in early human pregnancy. Annales Chirurgiae et Gynaecologiae Fenniae 63: 489–491 (1974).
Kanto, J.; Erkkola, R. and Sellman, R.: Accumulation of diazepam and N-demethyldiazepam in the fetal blood during labour. Annales Clinical Research 5: 375–379 (1973).
Kanto, J. and Iisalo, E.U.M.: Diazepam as an inductive agent in two kinds of combination anaesthesia: The disappearance of diazepam and its metabolites from the plasma. Annales Chirurgiae et Gynaecologiae Fenniae 62: 251–255 (1973).
Kanto, J.; Iisalo, E.; Lehtinen, V. and Salminen, J.: The concentrations of diazepam and its metabolites in the plasma after an acute and chronic administration. Psychopharmacologia (Berl.) 36: 123–131 (1974).
Kaplan, S.A.; Jack, M.L.; Alexander, K. and Weinfeld, R.E.: Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. Journal of Pharmaceutical Sciences 62: 1789–1796 (1973).
Kay, B.: A clinical assessment of the use of etomidate in children. British Journal of Anaesthesia 48: 207–211 (1976a).
Kay, B.: Clinical effects of changes of formulation of etomidate; in Abstracts of the 6th World Congress of Anesthesiology, p.96 (Excerpta Medica, Amsterdam 1976b).
Klotz, U.; Avant, G.R.; Hoyumpa, A.; Schenker, S. and Wilkinson, G.R.: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. Journal of Clinical Investigation 55: 347–359 (1975).
Korttila, K.: Recovery and driving after brief anesthesia; in Johnstone (Ed) New Directions in Anesthesiology. In press (Medical Examination. New York 1977).
Korttila, K. and Kangas, L.: Unchanged protein binding and the increase of serum diazepam levels after food intake. Acta Pharmacologica et Toxicologica. In press (1977).
Korttila, K. and Linnoila, M.: Skills related to driving after intravenous diazepam, flunitrazepam or droperidol. British Journal of Anaesthesia 46: 961–969 (1974).
Korttila, K. and Linnoila, M.: Absorption and sedative effects of diazepam after oral administration and intramuscular administration into the vastus lateralis and deltoid muscle. British Journal of Anaesthesia 47: 857–862 (1975a).
Korttila, K. and Linnoila, M.: Recovery and skills related to driving after intravenous sedation: Dose-response relationship with diazepam. British Journal of Anaesthesia 47: 457–463 (1975b).
Korttila, K.: Linnoila, M.; Ertama, P. and Hakkinen, S.: Recovery and simulated driving after intravenous anesthesia with thiopental, methohexital, propanidid, or alphadione. Anesthesiology 43: 291–299 (1975).
Korttila, K.; Mattila, M.J. and Linnoila, M.: Prolonged recovery after diazepam sedation: The influence of food, charcoal ingestion, and injection rate on the effects of intravenous diazepam. British Journal of Anaesthesia 48: 333–340 (1976a).
Korttila, K.; Sothman, A. and Andersson, P.: Polyethylene glycol as a solvent for diazepam: Bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutions. Acta Pharmacologica et Toxicologica 39: 107–117 (1976b).
Kurz, H.: Einfluss de physikalisch-chemischen Eigenschaften von Kurznarkotica auf den “hang over.” Naunyn-Schmiedebergs Archiv Fur Pharmakologie Und Experimentelle Pathologie 255: 33–34 (1966).
Lau, S.; Gwynn, G.J. and Domino, E.G.: Ketamine pharmacokinetics in Macaca mulatta using a gas chromatographymass fragmentography assay. Pharmacologist 18: 214 (1976).
Lean, T.H.: Ratnam, S.S. and Sivasamboo, R.: Use of benzodiazepines in the management of eclampsia. Journal of Obstetrics and Gynaecology of the British Commonwealth 75: 856–862 (1968).
Lingjaerde, O. and Nordbø, K.: Thromboftebitt efter intravenøs injeksjon av diazepam. Tidskrift der Norske Laegeforening 94: 455–456 (1974).
Linnoila, M.; Korttila, K. and Mattila, M.J.: Effect of food and repeated injections on diazepam serum levels. Acta Pharmacologica et Toxicologica 36: 181–186 (1975).
Little, B.; Chang, T.; Chucot, L.; Dill, W.A.; Enrile, L.; Glazko, A.J.; Jassani, M.; Kretchmer, H. and Sweet, A.Y.: A study of ketamine as an obstetrical anesthetic agent. American Journal of Obstetrics and Gynecology 113: 247–260 (1972).
Lo, J.L. and Cumming, J.F.: Interaction between sedative premedicants and ketamine in man and in isolated perfused rat livers. Anesthesiology 43: 307–312 (1975).
Mahomedy, M.C.; Downing, J.W. and Mahomedy, Y.H.: Alfathesin for anaesthetic induction at caesarean section. South African Medical Journal 49: 1095–1096 (1975).
Mahon, W.A.; Inaba, T.; Umeda, T.; Tsutsumi, E. and Stone, R.: Biliary elimination of diazepam in man. Clinical Pharmacology and Therapeutics 19: 443–450 (1976).
Marcucci, F.: Mussini, E.; Airoldi, L.: Fanelli, R.; Frigerio, A.; De Nadai, F.; Bizzi, A.; Rizzo, M.; Morselli, P.L. and Garattini, S.: Analytical and pharmacokinetic studies on butyrophenones Climica Chimica Acta 34: 321–332 (1971).
Marietta, M.P.; White, P.F.; Pudwill, C.R.; Way, W.L. and Trevor, A.J.: Biodisposition of ketamine in the rat: Self-induction of metabolism. Journal of Pharmacology and Experimental Therapeutics 196: 536–544 (1976).
Mark, L.C.: Thiobarbiturates; in Papper and Kitz (Eds) Uptake and Distribution of Anesthetic Agents, p.289–297 (McGraw-Hill, New York 1963).
Mark, L.C.: On species differences II: Computers. Anesthesiology 27: 113–114 (1966).
Marks, G.S. and Taub, H.: Drug induced porphyrin biosynthesis. X: Potentiation of propanidid induced elevation of 6-aminolevulinic acid synthetase and porphyrins in chick embryo liver by the carboxylesterase inhibitor bis [p-nitrophenyl] phosphate. Canadian Journal of Physiology and Pharmacology 51: 700–704 (1973).
McCarthy, D.A.; Chen, G.; Kaump, D.H. et al.: General anesthetic and other pharmacological properties of 2-(O-chlorophenyl)-2-methylamino cyclohexanone HCl (CI581). Journal of New Drugs 5: 21–33 (1965).
McKechnie, F.B. and Converse, J.C.: Placental transmission of thiopental. American Journal of Obstetrics and Gynecology 70: 639–644 (1955).
Meuldermans, W.E.G. and Heykants, J.J.P.: The plasma protein binding and distribution of etomidate in dog, rat, and human blood. Archives Internationales de Pharmacodynamie et de Therapie 221: 150–162 (1976).
Mirkin, B.L.: Drug distribution in pregnancy; in Boreus (Ed) Fetal Pharmacology, p.1–26 (Raven Press, New York 1973).
Morgan, M.; Lumley, J. and Whitwam, J.G.: Etomidate, a new water-soluble non-barbiturate intravenous induction agent. Lancet 1: 955–956 (1975).
Muller, W. and Wollert, U.: Characterization of the binding of benzodiazepines to human serum albumin. Naunyn-Schmiedeberg’s Archives of Pharmacology 280: 229–237 (1973).
Novelli, G.P.; Marsili, M. and Lorenzi, P.; Influence of liver metabolism on the actions of Althesin and thiopentone. British Journal of Anaesthesia 47: 913–916 (1975).
Patel, V.K. and Johnson, G.E.: The influence of chronic ethanol consumption on the distribution of thiopental in rats. Canadian Journal of Physiology and Pharmacology 53: 669–672 (1975).
Peskar, B. and Spector, S.: Quantitative determination of diazepam in blood by radioimmunoassay. Journal of Pharmacology and Experimental Therapeutics 186: 167–172 (1973).
Price, H.L.: General anesthetics; in Goodman and Gilman (Eds) The Pharmacological Basis of Therapeutics, p.89–96 (Macmillan New York 1975).
Price, H.L.; Kornat, P.J.; Safar, J.N.; Connor, E.H. and Price, M.L.: The uptake of thiopental by body tissues and its relation to the duration of narcosis. Clinical Pharmacology and Therapeutics 1: 16–22 (1960).
Putter, J.: Uber den fermentativen Abbau des Propanidid; in Horatz, Frey and Zindler (Eds) Die intravenose Kuranarkose mit dem Phenoxyessigaurederivat Propanidid (Epontol), p.61–77 (Springer-Verlag, Berlin 1965).
Putter, J. and Stockhausen, H.: Neue pharmacokinetische Unter suchungsergebnisse uber Propanidid; in Zindler, Yamamura, and Wirth (Eds) Intravenose Narkose mit Propanidid, p.3–15 (Springer-Verlag, Berlin 1973).
Rann, E.; Dayton, P.G. and Fredricksen, E.L.: Lack of effect of halothane on the metabolism of thiopentone in man. British Journal of Anaesthesia 41: 503–505 (1969).
Saidman, L.J.; Uptake, distribution and elimination of barbiturates; in Eger (Ed) Anesthetic Uptake and Action, p.264–284 (Williams & Wilkins Company, Baltimore 1974).
Saidman, L.J. and Eger II. EL: The effect of thiopental metabolism on duration of anesthesia. Anesthesiology 27: 118–126 (1966).
Schaer, H. and Jenny, E.: Plasmakonzentration und Plasmaeiweiszbindung von Droperidol und Fentanyl wahrend der Neuroleptanasthesie beim Menschen; in Henschel (Ed) Neue Klinische Aspekte der Neuroleptanalgesie, p. 15–20 (Schattauer, Stuttgart 1970).
Schiff, D.: Chan, G. and Stern, L.: Fixed drug combinations and the displacement of bilirubin from albumin. Pediatrics 48: 139–141 (1971).
Schleimer, R.; Benjamini, E.; Eisele, J. and Henderson, G.: Pharmacokinetics of fentanyl in man. Federation Proceedings 35: 546 (1976).
Scholtan, W. and Lie, S.K.: Kolloid-chemische Eigenschaften eines neuen Kurznarkoticums. Arzneimittel-Forschung 16: 679–691 (1966).
Schwartz, M.A.: Koechlin, B.A.; Postma, E.; Palmer, S. and Krol, G.: Metabolism of diazepam in rat, dog and man. Journal of Pharmacology and Experimental Therapeutics 149: 423–435 (1965).
Sellman, R.; Kanto, J. and Pekkarinen, A.: Biliary excretion of diazepam and its metabolites in man. Acta Pharmacologica et Toxicologic 37: 242–249 (1975a).
Sellman, R.; Kanto, J.; Raijola, E. and Pekkarinen, A.: Human and animal study on elimination from plasma and metabolism of diazepam after chronic alcohol intake. Acta Pharmacologica et Toxicologica 36: 33–38 (1975b).
Sellman, R.; Kanto, J. Raijola, E. and Pekkarinen, A.: Induction effect of diazepam on its own metabolism. Acta Pharmacologica et Toxicologica 37: 345–351 (1975c).
Sennello, L.T. and Kohn, F.E.; Gas chromatographic determination of thiopental in plasma using an alkali flame ionization detector. Analytical Chemistry 46: 752–755 (1974).
Shideman, F.E.; Kelly, A.R.; Lee, L.E. et al.: The role of the liver in the detoxification of thiopental (Pentothal) by man. Anesthesiology 10: 421–428 (1949).
Siebke, H.; Ellertsen, B.B. and Lind, B.: Reactions to intravenous injections of diazepam. British Journal of Anaesthesia 48: 1187–1188 (1976).
Soudijn, W. and van Wijngaarden, I.: Localization of 3H-pimozide in the rat brain in relation to its anti-amphetamine potency. Journal of Pharmacy and Pharmacology 24: 773–780 (1972).
Soudijn, W.; van Wijngaarden, I. and Allewijn, F.: Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. European Journal of Pharmacology 1: 47–57 (1967).
Soudijn, W.; van Wijngaarden, I. and Janssen, P.A.J.: Biotransformation of neuroleptanalgesics. International Anesthesiology Clinics 12: 145–155 (1974).
Strunin, L.; Strunin, J.M.; Knights, K. and Ward, M.E. Metabolism of 14C-labelled alphaxalone in man. British Journal of Anaesthesia 46: 319–320 (1974).
Strunin, L.: Strunin, J.M.; Knights, K. and Ward, M.D.: Metabolism of 14C-labelled alphaxalone in man; in Arias, Llaurado. Nalda and Lunn (Eds) Recent Progress in Anaesthesiology and Resuscitation, p. 100–106 (Excerpta Medica, Amsterdam 1975).
Swerdlow, M. and Moore, B.A.: A dose-duration trial with propanidid. British Journal of Anaesthesia 39: 573–577 (1967).
Tammisto, T.; Takki, S.; Tigerstedt, I. and Kauste, A.: A comparison of Althesin and thiopentone in induction of anaesthesia. British Journal of Anaesthesia 45: 100–107 (1973).
Thiessen, J.J.; Sellers, E.M.; Denbeigh, P. and Dolman, L.: Plasma protein binding of diazepam and tolbutamide in chronic alcoholics. Journal of Clinical Pharmacology 16: 345–351 (1976).
Trevor, A.J.; Marietta, M.P. and Way, W.L.: The pharmacology of the optical isomers of ketamine. Pharmacologist 18: 214 (1976).
Tsutsumi, E.; Inaba, T.; Mahon, W.A. and Kalow, W.: The displacing effect of a fatty acid on the binding of diazepam to human serum albumin. Biochemical Pharmacology 24: 1361–1362 (1975).
van der Kleijn, E.; van Rossum, J.M.; Muskens, A.T.J.M. and Rijntjes, N.V.M.: Pharmacokinetics of diazepam in dogs, mice and humans. Acta Pharmacologica et Toxicologica 29: 109–129 (1971).
Van Hamme, M.J.; Ambre, J.J. and Ghoneim, M.M.: Determination of etomidate plasma concentrations by mass fragmentography. Journal of Pharmaceutical Sciences, in press (1977).
Van Hamme, M.J. and Ghoneim, M.M.: A sensitive gas chromatographic assay for thiopentone in plasma. British Journal of Anaesthesia, in press (1977).
van Wijngaarden, I. and Soudijn, W.: The metabolism and excretion of the analgesic fentanyl by Wistar rats. Life Sciences 7: 1239–1244 (1968).
von Dardel, O.; Mebius, C. and Mossberg, T.: Diazepam in emulsion form for intravenous usage. Acta Anaesthesiologica Scan-dinavica 20: 221–224 (1976).
Waddell, W.J. and Butler, T.C.: The distribution and excretion of phenobarbital. Journal of Clinical Investigation 36: 1217–1226 (1957).
White, P.F.; Johnston, R.R. and Pudwill, C.R.: Interactions of ketamine and halothane in rats. Anesthesiology 42: 179–186 (1975).
White, P.F.: Marietta, M.P.; Pudwill, C.R.; Way, W.L. and Trevor, A.J.: Effects of halothane anesthesia on (he biodisposition of ketamine in rats. Journal of Pharmacology and Experimental Therapeutics 196: 545–555 (1976).
Wieber, J.; Gugler, R.; Hengstmann, J.H. and Dengler, H.J.: Pharmacokinetics of ketamine in man. Anaesthesist 24: 260–263 (1975).
Zbinden, G. and Randall, L.O.: Pharmacology of benzodiazepines: Laboratory and clinical correlations; in Garattini and Shore (Eds) Advances in Pharmacology, Vol. 5, p.213–291 (Academic Press, New York 1967).
Zingales, I.A.: A gas chromatographic method for the determination of haloperidol in human plasma. Journal of Chromatography 54: 15–24 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghoneim, M.M., Korttila, K. Pharmacokinetics of Intravenous Anaesthetics: Implications for Clinical Use. Clin Pharmacokinet 2, 344–372 (1977). https://doi.org/10.2165/00003088-197702050-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-197702050-00003